Responsible Research and Innovation in the context of human cognitive enhancement: some essential features

References

• Blank, R. H. 2016. Cognitive Enhancement: Social and Public Policy Issues. Basingstoke: Palgrave Macmillan.
   Google Scholar
• Bostrom, N. 2003. The Transhumanism FAQ. Version 2.1. World Transhumanist Association. Accessed February 18, 2017. http://www.nickbostrom.com/views/transhumanist.pdf.
   Google Scholar
• Bostrom, N., and R. Roache. 2008. “Ethical Issues in Human Enhancement.” In New Waves in Applied Ethics, edited by J. Ryberg, T. Petersen, and C. Wolf, 120–152. Basingstoke: Palgrave Macmillan.
   Google Scholar
• British Medical Association. 2015. “Cognitive Enhancing Drugs and the Workplace.” Accessed November 24, 2016. https://www.bma.org.uk/advice/employment/occupational-health/cognitive-enhancing-drugs.
   Google Scholar
• Buchanan, A. E. 2011. Beyond Humanity?: The Ethics of Biomedical Enhancement. Oxford: Oxford University Press.
   Google Scholar
• Buchanan, A., D. W. Brock, N. Daniels, and D. Wickler. 2000. From Chance to Choice: Genetics and Justice. Cambridge: Cambridge University Press.
   Google Scholar
• Cakic, V. 2009. “Smart Drugs for Cognitive Enhancement: Ethical and Pragmatic Considerations in the Era of Cosmetic Neurology.” Journal of Medical Ethics 35: 611–615. doi: 10.1136/jme.2009.030882
   PubMed Web of Science ®Google Scholar
• Caplan, A. 2002. “No-brainer: Can We Cope with the Ethical Ramifications of New Knowledge of the Human Brain?” In Neuroethics: Mapping the Field, edited by S. J. Marcus, 95–106. New York, NY: The Dana Press.
   Google Scholar
• Caplan, A. 2003. “Is Better Best?” Scientific American 289: 104–105. doi: 10.1038/scientificamerican0903-104
   PubMed Web of Science ®Google Scholar
• Castaldi, S., U. Gelatti, G. Orizio, U. Hartung, A. M. Moreno-Londono, M. Nobile , and P. J. Schulz. 2012. “Use of Cognitive Enhancement Medication among Northern Italian University Students.” Journal of Addiction Medicine 6 (2): 112–117. doi: 10.1097/ADM.0b013e3182479584
   PubMed Web of Science ®Google Scholar
• Caviola, L., and N. S. Faber. 2015. “Pills or Push-Ups? Effectiveness and Public Perception of Pharmacological and Non-Pharmacological Cognitive Enhancement.” Frontiers in Psychology 6: 1852. doi:10.3389/fpsyg.2015.01852.
   PubMed Web of Science ®Google Scholar
• Chatterjee, A. 2004. “Cosmetic Neurology: The Controversy Over Enhancing Movement, Mentation, and Mood.” Neurology 63 (6): 968–974. doi: 10.1212/01.WNL.0000138438.88589.7C
   PubMed Web of Science ®Google Scholar
• Coenen, C., and A. Ferrari. 2012. “European Governance Activities on Human Cognitive Enhancement.” Fourth Annual SNET Conference, University of Twente, Enschede, The Netherlands, October 22–25.
   Google Scholar
• Coenen, C., M. Schuijff, M. Smits, P. Klaassen, L. Hennen, M. Rader, and G. Wolbring. 2009. Human Enhancement. Brussels: European Parliament.
   Google Scholar
• Daniels, Norman. 1985. Just Health Care. New York: Cambridge University Press.
   Google Scholar
• Daniels, N. 2000. “Normal Functioning and the Treatment-enhancement Distinction.” Cambridge Quarterly of Healthcare Ethics 9 (3): 309–322. doi: 10.1017/S0963180100903037
   PubMed Web of Science ®Google Scholar
• Davis, N. J. 2014. “Transcranial Stimulation of the Developing Brain: A Plea for Extreme Caution.” Frontiers in Human Neuroscience 8: 1–4. doi: 10.3389/fnhum.2014.00600
   PubMed Web of Science ®Google Scholar
• Deans, L., N. Hammond-Browning, and R. ter Meulen 2010. “ EPOCH Project Ethics in Public Policy Making: The Case of Human Enhancement.” Final Report & Policy Recommendations.
   Google Scholar
• De Jongh, R., I. Bolt, M. Schermer, and B. Olivier. 2008. “Botox for the Brain: Enhancement of Cognition, Mood and Pro-social Behavior and Blunting of Unwanted Memories.” Neuroscience & Biobehavioral Reviews 32 (2008): 760–776. doi: 10.1016/j.neubiorev.2007.12.001
   PubMed Web of Science ®Google Scholar
• Dijkstra, A. M., and M. Schuijff. 2016. “Public Opinions about Human Enhancement can Enhance the Expert-only Debate: A Review Study.” Public Understanding of Science 25 (5): 588–602. doi: 10.1177/0963662514566748
   PubMed Web of Science ®Google Scholar
• Dresler, M., A. Sandberg, K. Ohla, C. Bublitz, C. Trenado, A. Mroczko-Wąsowicz, S. Kühn, and D. Repantis. 2013. “Non-pharmacological Cognitive Enhancement.” Neuropharmacology 64 (2013): 529–543. doi: 10.1016/j.neuropharm.2012.07.002
   PubMed Web of Science ®Google Scholar
• Dubljević, Veljko. 2015. “Neurostimulation Devices for Cognitive Enhancement: Toward a Comprehensive Regulatory Framework.” Neuroethics 8: 115–126. doi: 10.1007/s12152-014-9225-0
   Web of Science ®Google Scholar
• Farah, M. J. 2015. “The Unknowns of Cognitive Enhancement. Can Science and Policy Catch Up with Practice?” Science 350 (6259): 379–380. doi: 10.1126/science.aad5893
   PubMed Web of Science ®Google Scholar
• Farah, M. J., J. Illes, R. Cook-Deegan, H. Gardner, E. Kandel, P. King, E. Parens, B. Sahakian, and P. R. Wolpe. 2004. “Science and Society: Neurocognitive Enhancement: What Can We Do and What Should We Do?” Nature Reviews Neuroscience 5: 421–425. doi: 10.1038/nrn1390
   PubMed Web of Science ®Google Scholar
• Farah, M. J., M. E. Smith, I. Ilieva, and R. H. Hamilton. 2014. “Cognitive Enhancement.” Wiley Interdisciplinary Reviews: Cognitive Science 5: 95–103. doi: 10.1002/wrna.1200
   PubMed Web of Science ®Google Scholar
• Ferrari, A., C. Coenen, and A. Grunwald. 2012. “Visions and Ethics in Current Discourse on Human Enhancement.” Nanoethics 6: 215–229. doi: 10.1007/s11569-012-0155-1
   Web of Science ®Google Scholar
• Fitz, N. S., R. Nadler, P. Manogaran, E. W. Chong, and P. B. Reiner. 2014. “Public Attitudes Toward Cognitive Enhancement.” Neuroethics 7: 173–188. doi: 10.1007/s12152-013-9190-z
   Web of Science ®Google Scholar
• Fitz, N. S., and P. B. Reiner. 2013. “The Challenge of Crafting Policy for Do-it-yourself Brain Stimulation.” Journal of Medical Ethics 1–3. doi:10.1136/medethics-2013-101458.
   PubMed Web of Science ®Google Scholar
• Forlini, C., W. Hall, B. Maxwell, S. M. Outram, P. B. Reiner, D. Repantis, M. Schermer, and E. Racine. 2013. “Navigating the Enhancement Landscape. Ethical Issues in Research on Cognitive Enhancers for Healthy Individuals.” EMBO Reports 14 (2): 123–128. doi: 10.1038/embor.2012.225
   PubMed Web of Science ®Google Scholar
• Forsberg, E-M., C. Shelley-Egan, E. Thorstensen, L. Landeweerd, and B. Hofmann. 2017. Ethical Frameworks for the Assessment of Human Cognitive Enhancement Applications. Cham: Springer Brief Series in Technology Ethics.
   Google Scholar
• Franke, A. G., C. Bagusat, P. Dietz, I. Hoffmann, P. Simon, R. Ulrich, and K. Lieb. 2013. “Use of Illicit and Prescription Drugs for Cognitive or Mood Enhancement among Surgeons.” BMC Medicine 11: 109. doi:10.1186/1741-7015-11-102.
   PubMed Web of Science ®Google Scholar
• Frati, P., C. Kyriakou, A. Del Rio, E. Marinelii, G. Montanari Vergallo, S. Zammi, and F. P. Busardo. 2015. “Smart Drugs and Synthetic Androgens for Cognitive and Physical Enhancement: Revolving Doors of Cosmetic Neurology.” Current Neuropharmacology 13 (1): 5–11. doi: 10.2174/1570159X13666141210221750
   PubMed Web of Science ®Google Scholar
• Giubilini, A., and S. Sanyal. 2015. “The Ethics of Human Enhancement.” Philosophy Compass 10 (2015): 233–243. doi: 10.1111/phc3.12208
   Web of Science ®Google Scholar
• Goodman, R. 2010. “Cognitive Enhancement, Cheating, and Accomplishment.” Kennedy Institute of Ethics Journal 20 (2): 145–160. doi: 10.1353/ken.0.0309
   PubMed Web of Science ®Google Scholar
• Goold, I., and H. Maslen. 2014. “Must the Surgeon Take the Pill? Negligence Duty in the Context of Cognitive Enhancement.” The Modern Law Review 77 (1): 60–86. doi: 10.1111/1468-2230.12056
   Web of Science ®Google Scholar
• Greely, H., B. Sahakian, J. Harris, R. C. Kessler, M. Gazzaniga, P. Campbell, and M. J. Farah. 2008. “Towards Responsible Use of Cognitive-enhancing Drugs by the Healthy.” Nature 456: 702–705. doi: 10.1038/456702a
   PubMed Web of Science ®Google Scholar
• Hagger, L., and G. H. Johnson. 2011. “‘Super Kids’: Regulating the Use of Cognitive and Psychological Enhancement in Children.” Law, Innovation and Technology 3 (1): 137–166. doi: 10.5235/175799611796399867
   Google Scholar
• Hall, W. 2004. “Feeling ‘Better than Well’.” EMBO Reports 5 (12): 1105–1109. doi: 10.1038/sj.embor.7400303
   PubMed Web of Science ®Google Scholar
• Hamilton, R., S. Messing, and A. Chatterjee. 2011. “Rethinking the Thinking Cap: Ethics of Neural Enhancement Using Noninvasive Brain Stimulation.” Neurology 76 (2): 187–193. doi: 10.1212/WNL.0b013e318205d50d
   PubMed Web of Science ®Google Scholar
• Hartley, S., F. Gillund, L. van Hove, and F. Wickson. 2016. “Essential Features of Responsible Governance of Agricultural Biotechnology.” PLOS Biology 14 (5): e1002453. doi:10.1371/journal.pbio.1002453.
   PubMed Web of Science ®Google Scholar
• Hofmann, B., D. Haustein, and L. Landeweerd. 2016. “Smart-glasses: Exposing and Elucidating the Ethical Issues.” Science and Engineering Ethics 136 (17): 1–21.
   Google Scholar
• van den Hoven, J., K. Jacob, L. Nielsen, F. Roure, L. Rudze, J. Stilgoe, K. Blind, A. L. Guske, and C. Martinez Riera. 2013. Options for Strengthening Responsible Research and Innovation: Report of the Expert Group on the State of the Art in Europe on Responsible Research and Innovation. Brussels: European Commission.
   Google Scholar
• Kadosh, R. C., N. Levy, J. O’Shea, N. Shea, and J. Savulescu. 2012. “The Neuroethics of Non-invasive Brain Stimulation.” Current Biology 22 (4): R108–R111. doi: 10.1016/j.cub.2012.01.013
   PubMed Web of Science ®Google Scholar
• Kroutil, L. A., D. L. Van Brunt, M. A. Herman-Stahl, D. C. Heller, R. M. Bray, and M. A. Penne. 2006. “Nonmedical Use of Prescription Stimulants in the United States.” Drug and Alcohol Dependence 84 (2): 135–143. doi: 10.1016/j.drugalcdep.2005.12.011
   PubMed Web of Science ®Google Scholar
• Lucke, J. C. 2012. “Empirical Research on Attitudes Toward Cognitive Enhancement is Essential to Inform Policy and Practice Guidelines.” AJOB Primary Research 3 (1): 58–60. doi: 10.1080/21507716.2011.645268
   Google Scholar
• Mache, S., P. Eickenhorst, K. Vitzthum, B. F. Klapp, and D. A. Groneberg. 2012. “Cognitive-enhancing Substance Use at German Universities: Frequency, Reasons and Gender Differences.” Wiener Medizinische Wochenschrift 162: 262–271. doi: 10.1007/s10354-012-0115-y
   PubMedGoogle Scholar
• Mann, S. P., and B. J. Sahakian. 2015. “The Increasing Lifestyle Use of Modafinil by Healthy People: Safety and Ethical Issues.” Current Opinion in Behavioral Sciences 4 (August 2015): 136–141. doi: 10.1016/j.cobeha.2015.05.004
   Google Scholar
• Maslen, H., N. Faulmüller, and J. Savulescu. 2014. “Pharmacological Cognitive Enhancement – How Neuroscientific Research Could Advance Ethical Debate.” Frontiers in Systems Neuroscience 8: 1–12. doi: 10.3389/fnsys.2014.00107
   PubMedGoogle Scholar
• Mohamed, A. D. 2014. “Neuroethical Issues in Pharmacological Cognitive Enhancement.” Wiley Interdisciplinary Reviews: Cognitive Science 5: 533–549.
   PubMed Web of Science ®Google Scholar
• Muhammed, K. 2014. “Cosmetic Neurology: The Role of Healthcare Professionals.” Medicine, Health Care and Philosophy 17: 239–240. doi: 10.1007/s11019-013-9497-x
   PubMed Web of Science ®Google Scholar
• Nadler, R. C., and P. B. Reiner. 2010. “A Call for Data to Inform Discussion on Cognitive Enhancement.” BioSocieties 5 (4): 481–482. doi: 10.1057/biosoc.2010.30
   Web of Science ®Google Scholar
• Nicholson, P., G. Mayho, and C. Sharp. 2015. Cognitive Enhancing Drugs and the Workplace. London: British Medical Association.
   Google Scholar
• Nuffield Council on Bioethics. 2013. Novel Neurotechnologies: Intervening in the Brain. London: Nuffield Council on Bioethics.
   Google Scholar
• Outram, S. M. 2012. “Ethical Considerations in the Framing of the Cognitive Enhancement Debate.” Neuroethics 5 (2): 173–184. doi: 10.1007/s12152-011-9131-7
   Web of Science ®Google Scholar
• Outram, S. M., and E. Racine. 2011. “Examining Reports and Policies on Cognitive Enhancement; Approaches, Rationale, and Recommendations.” Accountability in Research 18: 323–341. doi: 10.1080/08989621.2011.606734
   PubMed Web of Science ®Google Scholar
• Partridge, B. J., S. K. Bell, J. C. Lucke, S. Yeates, and W. D. Hall. 2011. “Smart Drugs ‘as Common as Coffee’: Media Hype about Neuroenhancement.” PloS one 6 (11): e28416. doi: 10.1371/journal.pone.0028416
   PubMed Web of Science ®Google Scholar
• Pustovrh, T., and F. Mali. 2014. “Exploring Some Challenges of the Pharmaceutical Cognitive Enhancement Discourse: Users and Policy Recommendations.” Neuroethics 7: 137–158. doi: 10.1007/s12152-013-9192-x
   Web of Science ®Google Scholar
• Racine, E., and C. Forlini. 2010. “Cognitive Enhancement, Lifestyle Choice or Misuse of Prescription Drugs?.” Neuroethics 3 (2010): 1–4. doi: 10.1007/s12152-008-9023-7
   Web of Science ®Google Scholar
• Roco, M. C., W. S. Bainbridge, B. Tonn, and G. Whitesides. 2013. “ Convergence of Knowledge, Technology and Society: Beyond Convergence of Nano-bio-info-cognitive Technologies.” Accessed 17 November 2016. http://www.wtec.org/NBIC2/Docs/FinalReport/Pdf-secured/NBIC2-FinalReport-WEB.pdf.
   Google Scholar
• Sahakian, B., and S. Morein-Zamir. 2007. “Professor’s Little Helper.” Nature 450 (20): 1157–1159. doi: 10.1038/4501157a
   PubMed Web of Science ®Google Scholar
• Sahakian, B. J., and S. Morein-Zamir. 2011. “Neuroethical Issues in Cognitive Enhancement.” Journal of Psychopharmacology 25 (2): 197–204. doi: 10.1177/0269881109106926
   PubMed Web of Science ®Google Scholar
• Santoni de Sio, F., N. Faulmüller, and N. A. Vincent. 2014. “How Cognitive Enhancement Can Change Our Duties.” Frontiers in Systems Neuroscience 8: 311. doi:10.3389/fnsys.2014.00131.
   Google Scholar
• Savulescu, J. 2006. “Justice, Fairness, and Enhancement.” Annals of the New York Academy of Sciences 1093: 321–338. doi: 10.1196/annals.1382.021
   PubMed Web of Science ®Google Scholar
• Schelle, K. J., N. Faulmüller, L. Caviola, and M. Hewstone. 2014. “Attitudes Toward Pharmacological Cognitive Enhancement – A Review.” Frontiers in Systems Neuroscience 8: 1–14. doi: 10.3389/fnsys.2014.00053
   PubMedGoogle Scholar
• Schermer, M., I. Bolt, R. de Jongh, and B. Olivier. 2009. “The Future of Psychopharmacological Enhancements: Expectations and Policies.” Neuroethics 2: 75–87. doi: 10.1007/s12152-009-9032-1
   Web of Science ®Google Scholar
• Sharp, C. 2016. “Cognitive Enhancers – Performance or Problem?” Occupational Medicine 66: 88–89. doi: 10.1093/occmed/kqv190
   PubMed Web of Science ®Google Scholar
• Stahl, B. C., G. Eden, and M. Jirotka. 2013. “Responsible Research and Innovation in Information and Communication Technology: Identifying and Engaging with the Ethical Implications of ICTs.” In Responsible Innovation: Managing the Responsible Emergence of Science and Innovation in Society, edited by R. Owen, J. Bessant, and M. Heintz, 199–218. London: Wiley.
   Google Scholar
• Stilgoe, J., R. Owen, and P. Macnaghten. 2013. “Developing a Framework for Responsible Innovation.” Research Policy 42 (2013): 1568–1580. doi: 10.1016/j.respol.2013.05.008
   Web of Science ®Google Scholar
• TAB, Office of Technology Assessment at the German Bundestag. 2011. “Pharmacological Interventions to Improve Performance as a Social Challenge.” Accessed September 23, 2016. https://www.tab-beim-bundestag.de/en/pdf/publications/summarys/TAB-Arbeitsbericht-ab143_Z.pdf.
   Google Scholar
• TA Swiss. 2011. “ Tailor-made for Better Performance – Improving the Person with Human Enhancement.” Abridged version of the TA-SWISS study “Human Enhancement”, edited by Centre for Technology Assessment, TA56A72010. Bern, 2011. https://www.ta-swiss.ch/?redirect=getfile.php&cmd[getfile][uid]=1837.
   Google Scholar
• Ter Meulen, R. 2013. “Human Enhancement: A Policy Perspective for the European Union.” In Human Enhancement: Scientific, Ethical and Theological Aspects from a European Perspective, edited by T. Boer and R. Fischer, 10–24. Strasbourg: Church and Society Commission of the Conference of European Churches.
   Google Scholar
• The Academy of Medical Sciences, the British Academy, the Royal Academy of Engineering and the Royal Society. 2012. “Human Enhancement and the Future of Work.” (Report from a joint workshop, November 2012). Accessed November 17, 2016. https://acmedsci.ac.uk/file-download/35266-135228646747.pdf.
   Google Scholar
• Whetstine, L. M. 2015. “Cognitive Enhancement: Treating or Cheating?” Seminars in Pediatric Neurology 22 (3): 172–6. doi:10.1016/j.spen.2015.05.003.
   PubMed Web of Science ®Google Scholar
• Wickson, F., and E.-M. Forsberg. 2015. “Standardising Responsibility? The Significance of Interstitial Spaces.” Science and Engineering Ethics 21 (5): 1159–1180. doi:10.1007/s11948-014-9602-4.
   PubMed Web of Science ®Google Scholar
• Zwart, H. 2015. “ Deliverable D3.5 Final Report. Neuro-enhancement Responsible Research and Innovation (NERRI).” A project funded by the European Commission.
   Google Scholar